Churning out safer microbes for drug delivery.
Syvanen
Michael
M
D000818:Animals; D002455:Cell Division; D002470:Cell Survival; D003092:Colitis / Q000382:microbiology / Q000628:therapy; D016503:Drug Delivery Systems / Q000379:methods*; D015964:Gene Expression Regulation, Bacterial / Q000502:physiology*; D005818:Genetic Engineering / Q000379:methods; D006801:Humans; D007082:Ileum / Q000382:microbiology*; D016753:Interleukin-10 / Q000235:genetics* / Q000378:metabolism* / Q000627:therapeutic use; D013294:Lactococcus lactis / Q000166:cytology / Q000235:genetics* / Q000254:growth & development / Q000378:metabolism*; D016297:Mutagenesis, Site-Directed; D019936:Probiotics / Q000627:therapeutic use; D015202:Protein Engineering / Q000379:methods*; D013552:Swine; D013940:Thymidylate Synthase / Q000172:deficiency / Q000235:genetics / Q000378:metabolism
D016753:Interleukin-10; D013940:Thymidylate Synthase